FDA Brief

Warning letters Drugs

FDA warning letter to

Natural Ophthalmics, Inc.

High riskIssued Sep 11, 2023Posted Sep 12, 2023Center for Drug Evaluation and Research | CDER

FDA warned Natural Ophthalmics that six eye drop products are unapproved new drugs sold without FDA approval.

What happened

FDA reviewed https://natoph.com/ in August 2023. It found the site offering six eye drop products with claims to relieve dry eye, allergy symptoms, and cataract and to support eye tissues. FDA said the products are unapproved new drugs and that selling them in interstate commerce violates the law.

What FDA found

  1. The website claims the eye drops treat dry eye, allergy symptoms, and cataract, so FDA treats them as drugs.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. The products are new drugs because they are not generally recognized as safe and effective for their claimed uses.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. No FDA-approved application is in effect for any of the six eye drop products.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  4. Introducing or delivering the products for interstate commerce violates the law.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  5. Labeling the products as homeopathic does not exempt them from drug approval or other requirements.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)

What FDA wants

FDA asks Natural Ophthalmics to notify it in writing within 15 working days of the steps taken to correct the violations, including explanations, prevention steps, and supporting documents; if it disagrees, it should send reasoning and evidence. If correction cannot be completed in that time, it must state why and give a completion date.

Who should pay attention

  • brands or retailers selling homeopathic eye drops
  • consumers using dry eye, allergy, or cataract eye drops
  • ophthalmic product marketers making disease-treatment claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk